5 results

41 The emergence and clinical significance of artificial intelligence–enhanced electrocardiography
Yong-Soo Baek
KMSID: 1516087101   Cardiovasc Prev Pharmacother. 2024;6(2):41-47.   Published online 2024 April 26    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e7
      
48 Expectations and concerns regarding medical advertisements via large commercial medical platform advertising companies: a legal perspective
Raeun Kim, Hakyoung Park, Jiwon Shinn, Hun-Sung Kim
KMSID: 1516087102   Cardiovasc Prev Pharmacother. 2024;6(2):48-56.   Published online 2024 April 4    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e8
      
57 Changes in cardiovascular-related health behaviors after the end of social distancing: the 2023 Cardiovascular Disease Prevention Awareness Survey
Jaeyong Lee, Eunji Kim, Won-Young Lee, Eun-Jung Rhee, Hyeon Chang Kim
KMSID: 1516087100   Cardiovasc Prev Pharmacother. 2024;6(2):57-64.   Published online 2024 April 5    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e6
      
65 Cardiovascular risk assessment of newborns in Nigeria using the atherogenic index of plasma and its associations with gestational age and birth weight: a cross-sectional hospital-based study
Obinna Victory Obaji, Uche Charles Adizua, Ndubuisi Kennedy Chukwudi, Daberechi Kenneth Adiele, Justus Uchenna Onu
KMSID: 1516087103   Cardiovasc Prev Pharmacother. 2024;6(2):65-73.   Published online 2024 April 26    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e9
      
74 Cardiac rehabilitation using intensive lifestyle habituation combined with outdoor exercise in an urban forest environment for primary and secondary prevention of coronary artery disease: a feasibility test
Jong-Young Lee, Kee-Chan Joo, Kyung-Su Choi, Dae-Sik Yoon
KMSID: 1516087099   Cardiovasc Prev Pharmacother. 2024;6(2):74-83.   Published online 2024 April 25    DOI: http://dx.doi.org/10.36011/cpp.2024.6.e10
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap